ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 54 filers reported holding ALPINE IMMUNE SCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,061,678 | +12.9% | 92,723 | +1.3% | 0.00% | – |
| Q2 2023 | $940,692 | +69.7% | 91,507 | +27.4% | 0.00% | – |
| Q1 2023 | $554,342 | -9.8% | 71,806 | -14.1% | 0.00% | – |
| Q4 2022 | $614,394 | +32.4% | 83,591 | +29.6% | 0.00% | – |
| Q3 2022 | $464,000 | -7.0% | 64,480 | +10.1% | 0.00% | – |
| Q2 2022 | $499,000 | +13.2% | 58,554 | +19.1% | 0.00% | – |
| Q1 2022 | $441,000 | -38.4% | 49,155 | -5.0% | 0.00% | – |
| Q4 2021 | $716,000 | +32.8% | 51,745 | +2.4% | 0.00% | – |
| Q3 2021 | $539,000 | +43.0% | 50,538 | +20.7% | 0.00% | – |
| Q2 2021 | $377,000 | +57.1% | 41,862 | +84.5% | 0.00% | – |
| Q1 2021 | $240,000 | -18.6% | 22,684 | -3.2% | 0.00% | – |
| Q4 2020 | $295,000 | +195.0% | 23,426 | +106.6% | 0.00% | – |
| Q3 2020 | $100,000 | – | 11,338 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,571,450 | $17,640,000 | 4.25% |
| BVF INC/IL | 1,201,717 | $8,244,000 | 0.92% |
| Orbimed Advisors | 3,670,955 | $25,183,000 | 0.39% |
| TIGER MANAGEMENT L.L.C. | 137,728 | $945,000 | 0.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 475,450 | $3,262,000 | 0.12% |
| Hikari Power Ltd | 122,972 | $844,000 | 0.09% |
| ALPINE WOODS CAPITAL INVESTORS, LLC | 15,000 | $103,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 35,750 | $245,000 | 0.00% |
| DRW Securities, LLC | 10,000 | $69,000 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 134,542 | $923,000 | 0.00% |